A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus

BACKGROUND: Neramexane is a new substance that exhibits antagonistic properties at α(9)α(10 )cholinergic nicotinic receptors and N-methyl-D-aspartate receptors, suggesting potential efficacy in the treatment of tinnitus. METHODS: A total of 431 outpatients with moderate to severe subjective tinnitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Suckfüll, Markus, Althaus, Michael, Ellers-Lenz, Barbara, Gebauer, Alexander, Görtelmeyer, Roman, Jastreboff, Pawel J, Moebius, Hans J, Rosenberg, Tanja, Russ, Hermann, Wirth, Yvonne, Krueger, Hagen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031239/
https://www.ncbi.nlm.nih.gov/pubmed/21223542
http://dx.doi.org/10.1186/1472-6815-11-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031239/
https://www.ncbi.nlm.nih.gov/pubmed/21223542
http://dx.doi.org/10.1186/1472-6815-11-1

Ejemplares similares